N0n has just published a new victim: Vir Biotechnology, Inc.
ransomware.live recent, 16 November 2026
biopharmaceutical (chronic hepatitis infections) · United States | Hepatitis D and hepatitis B testing and treatment claims for a US biopharmaceutical company's franchise: 113,235,341 patient level rows covering 7,144,993 distinct patients, with ages, birth years, payer details…
Original source: ransomware.live recent